Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

FSD Pharma Inc Class B (0K9)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.4255 -0.0690    -13.95%
26/04 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.4275 / 0.4625
  • Day's Range: 0.4255 - 0.4255
Type:  Equity
Market:  Germany
ISIN:  CA35954B4047 
S/N:  A3E2LR
FSD Pharma B 0.4255 -0.0690 -13.95%

FSD Pharma Inc Company Profile

 
Get an in-depth profile of FSD Pharma Inc Class B, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

17

Equity Type

ORD

FSD Pharma Inc., a biotechnology company, operates in the pharmaceutical research and development business. Its lead candidate is FSD-201, an ultra-micronized palmitoylethanolamide for the treatment of inflammatory diseases. The company is also involved in the research and development of Lucid-Psych, a molecular compound identified for the treatment of mental health disorders; and Lucid-MS, a molecular compound identified for the treatment of neurodegenerative disorders. FSD Pharma Inc. was incorporated in 1998 and is headquartered in Toronto, Canada.

Contact Information

Address 199 Bay Street Suite 4000
Toronto, M5L 1A9
Canada
Phone 416 854 8884
Fax -

Top Executives

Name Age Since Title
Zeeshan Saeed 54 2021 Founder, CEO, President & Executive Co-Chairman
Anthony John Durkacz 48 2018 Founder & Executive Co-Chairman
Lakshmi P. Kotra 53 2021 CEO of Lucid & Director
Ravinder Kumar - 2022 Member of Advisory Board
Albert H.C. Wong - 2021 Member of Research & Clinical Advisory Board
John McGraw - 2022 Member of Advisory Board
Peter K. Stys - 2021 Member of Research & Clinical Advisory Board
Joga Gobburu - 2021 Member of Regulatory Advisory Board
Mary Melnyk - 2021 Member of Regulatory Advisory Board
Kwok Chow - 2022 Member of the Regulatory Advisory Board
Eleanor N. Fish - 2021 Member of Research & Clinical Advisory Board
Daniele Piomelli - 2022 Member of Research & Clinical Advisory Board
Adnan Bashir 54 2021 Independent Director
David G. P. Allan 82 2022 Member of Advisory Board
Shannon Dunn - 2021 Member of Research & Clinical Advisory Board
Hance Clarke - 2021 Member of Research & Clinical Advisory Board
Jason D. Sawyer - 2022 Member of Advisory Board
Navdeep Jaikaria 61 - Member of Advisory Board
Kevin Harrington 67 2023 Member of Advisory Board
Michael Zapolin 57 2023 Independent Director
Gerald V. David 72 2023 Member of Advisory Board
Eric William Hoskins 62 2023 Independent Director
Alexander Bar - 2023 Member of Advisory Board
Sanjiv Chopra 74 2024 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

HUGE Comments

Write your thoughts about FSD Pharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Mike Ivanitz
Mike Ivanitz Sep 15, 2023 13:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Only $18 more and i should break even. Bahahahah
Louie Mar
Louie Mar Feb 08, 2023 13:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
don't get tricked insiders buying to to inflate price this is garbage be aware
Bryan Johnson
Bryan Johnson Feb 28, 2022 1:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
cobourg facility sold
Neil Thorpe
Neil Thorpe Aug 05, 2021 12:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ceo fired and charged
Bryan Johnson
Bryan Johnson Aug 05, 2021 12:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
did he get charged?
Billy Smith
Billy Smith May 06, 2021 16:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This company is soooo junk
Bryan Johnson
Bryan Johnson Mar 08, 2021 16:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
fire the ceo!
William Jin
William Jin Mar 08, 2021 16:26
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sue him first then fire him
Mike Ivanitz
Mike Ivanitz Feb 09, 2021 14:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lets go FSD!
Louie Mar
Louie Mar Feb 09, 2021 14:39
Saved. See Saved Items.
This comment has already been saved in your Saved Items
where this company has nothing no product to speak off they are selling junk
Jesse Wissell
Jesse Wissell Feb 03, 2021 11:02
Saved. See Saved Items.
This comment has already been saved in your Saved Items
scam city baby
Iyhab Alali
Iyhab Alali Jan 14, 2021 12:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$1k worth turned into 20$ worth, what kind of black Magick is this
William Jin
William Jin Jan 14, 2021 12:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
huge magic
Linda Pinizzotto
Linda Pinizzotto Dec 17, 2020 21:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Huge is exactly that, a huge Rip Off woth false promises and never any media to keep anyone advised!!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email